


ECTE Alan Wayne Schoenbart Insider Trades for Echo Therapeutics Inc.


































Bulletin






Investor Alert







Tokyo Markets Close in:



Currencies
Europe Markets
London Markets


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Echo Therapeutics Inc.

                  OTC: ECTE
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Echo Therapeutics Inc.



Market closed
 --Quotes are delayed by 20 min
Jul 21, 2017, 5:20 p.m.


ECTE

/quotes/zigman/74143664/delayed


$
0.05




Change

0.00
0.00%

Volume
Volume 2,839
Quotes are delayed by 20 min








/quotes/zigman/74143664/delayed
Previous close

$
			0.05
		


$
				0.05
			
Change

0.00
0.00%





Day low
Day high
$0.05
$0.05










52 week low
52 week high

            $0.04
        

            $1.25
        


















Insider Activity


Individual




Alan Wayne Schoenbart



Mr. Alan W. Schoenbart, CPA, is Chief Executive Officer, CFO & Secretary at Echo Therapeutics, Inc. Mr. Schoenbart was previously employed as Chief Executive Officer & Director by Forticell Bioscience, Inc. and CFO, Treasurer, SVP-Finance & Administration by Vizacom, Inc. He received his undergraduate degree from Fairleigh Dickinson University.



Transactions


Date
Shares
Transaction
Value





03/21/2017
100,000


 
Award at $0 per share.


0


11/25/2016
28,000


 
Derivative/Non-derivative trans. at $0.34 per share.


9,520


03/01/2016
100,000


 
Award at $0 per share.


0


05/20/2015
2,500


 
Acquisition at $1.44 per share.


3,600





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Alan Wayne Schoenbart 
Chief Executive Officer, CFO, Secretary & Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/65801738/composite TLT+1.11%


/quotes/zigman/59386294/composite JNUG-5.94%


X




Powered by














Log In




8:19 PM EDT
July 23, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Open





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
5:37pAt least 9 dead after overheated tractor-trailer found outside Texas Walmart
5:01p‘Full transparency’ doesn’t mean what Scaramucci apparently thinks it means
5:00pStocks brace for volatility in earnings deluge; Fed meeting looms
4:53pThe dark side of cruises
4:53pIf you suddenly quit your job like Sean Spicer, here’s what you should do next
4:52pJohn McCain is a war hero — but think twice before saying he’s ‘battling’ cancer 
4:52pNever (ever) say these things to a co-worker
4:51pMy uncle with dementia needs long-term care — should I refinance his house?
4:49pThis is the deadliest time of your life to put on weight
4:46p5 easily avoidable reasons why millennials can’t have nice things (or save any money)
4:45pWhy house prices in gay neighborhoods are soaring
4:45pNearly 40% of adults don’t have life insurance — these startups are trying to change that
4:44pMarie Kondo says this one thing could be holding you back from falling in love
4:44pThis luxury credit card is only for truly big spenders
4:44pHow Elon Musk and shorter commutes could transform people’s lives
4:43pBanks have raised credit-card interest rates — but not savings account rates
4:43pThe most expensive city in the world is NOT New York or San Francisco
4:42p1 in 10 Americans say they will die in debt
4:40pShopping at Costco, and 5 other things that prove rich people are cheap
12:13aHeavy showers swamp New Orleans street with rainwater
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Insider Trading - Schoenbart Alan Wayne - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Schoenbart Alan Wayne





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2015-05-20Purchase
2015-05-204:29 pm
Echo Therapeutics Inc.
ECTE
Schoenbart Alan WayneCFO AND SECRETARY
2,500
$1.44
$3,600
2,500(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-03-01Option Award
2016-11-235:21 pm
N/AN/A
Echo Therapeutics Inc.
ECTE
Schoenbart Alan WayneINTERIM CEO, CFO AND SECRETARY
100,000
$0
102,500(Direct)
View


2016-03-01Option Award
2016-03-032:35 pm
N/AN/A
Echo Therapeutics Inc.
ECTE
Schoenbart Alan WayneCFO AND SECRETARY
100,000
$0
102,500(Direct)
View


2016-03-01Option Award
2016-03-032:35 pm
N/A2026-03-01
Echo Therapeutics Inc.
ECTE
Schoenbart Alan WayneCFO AND SECRETARY
150,000
$1.12
102,500(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sun, 23 Jul 2017 19:19:24 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  



















































SCHOENBART ALAN WAYNE Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      SCHOENBART ALAN WAYNE
                    

•   PHILADELPHIA, PA
                      
How do I update this listing?




                                             Schoenbart Alan Wayne is based out of Philadelphia.    WhaleWisdom has at least 1 13D/G filings in our database for Schoenbart Alan Wayne.
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from SCHOENBART ALAN WAYNE, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




schoenbart alan wayne


8 PENN CENTER

PHILADELPHIA
PA
                                                        
                                                    19103









Recent SEC Filings




SC 13D filed on 04/06/2017
4 filed on 03/22/2017
4 filed on 03/22/2017
4/A filed on 11/23/2016
4 filed on 03/03/2016
4 filed on 05/20/2015
3 filed on 01/07/2015











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





Echo Therapeutic (ECTE)


      HEALTH CARE
    

      774,501
    

      123,920.16
    

      1
    

      13D
    

      2017-03-21
    











Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free



















Alan Wayne Schoenbart, CPA - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East� More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100� More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD� More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM� More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Alan Wayne Schoenbart, CPA

Age : 58Public asset : 8,725 USDLinked companies :  Echo Therapeutics Inc 





Summary 



Mr. Alan W. Schoenbart, CPA, is Chief Executive Officer, CFO & Secretary at Echo Therapeutics, Inc. Mr. Schoenbart was previously employed as Chief Executive Officer & Director by Forticell Bioscience, Inc. and CFO, Treasurer, SVP-Finance & Administration by Vizacom, Inc.He received his undergraduate degree from Fairleigh Dickinson University.



Current positions of Alan Wayne Schoenbart, CPA 









 NameTitle
Since
 Echo Therapeutics Inc(Advanced Medical Equipment & Technology)
Chief Executive Officer, CFO, Secretary & Director
2014



Holdings of Alan Wayne Schoenbart, CPA 










 NameEquities%Valuation

Echo Therapeutics, Inc.174,5001.45%8,725 USD



Alan Wayne Schoenbart, CPA: Personal Network 







 NameLinked companies

Christine H. Olimpio Echo Therapeutics Inc 

Mike M. Goldberg Echo Therapeutics Inc 

Gary Sheldon Kohler Echo Therapeutics Inc 

William F. Grieco Echo Therapeutics Inc 

Vincent D. Enright Echo Therapeutics Inc 

Walter W. Witoshkin Echo Therapeutics Inc 

Sean F. Moran Echo Therapeutics Inc 

Robert S. Langer Echo Therapeutics Inc 

Shepard M. Goldberg Echo Therapeutics Inc 

Elazer R. Edelman Echo Therapeutics Inc 




Most Read News 




07/17 CHARLES SCHWAB : Low-fee BlackRock funds reel in cash but earnings disappoint



07/17DJCHARLES SCHARF : Bank of New York Mellon Names Former Visa Executive Scharf CEO and Chairman



07/17 PHILIP GREEN : You're hired - UK 'Apprentice' star Brady to chair Philip Green's company



07/17DJRUPERT MURDOCH : Tesla Names James Murdoch and Linda Johnson Rice to Board -- Update



07/17DJJAMES MURDOCH : Tesla Names James Murdoch and Linda Johnson to Board of Directors



07/18DJMARK LIGHT : Top Company News of the Day



07/18DJNELSON PELTZ : Peltz Goes on Offense In Break From Form -- WSJ



07/17 DAVID HENRY : Didn't pay your Macy's bill? Expect a text from Citigroup



07/17DJMARK LIGHT : Top Company News of the Day



07/17DJNELSON PELTZ : Peltz Seeks P&G Board Seat -- WSJ



More news

 


            © 2017 People and Ownership :    









Advertisement








Alan Wayne Schoenbart, CPA : Connections 



 Navidea Biopharmaceuticals Inc









Mike M. Goldberg




 Kala Pharmaceuticals Inc









Robert S. Langer




 Echo Therapeutics Inc









Christine H. Olimpio




 Gamco Natural Resources Gold & Incm Trst









Vincent D. Enright




 Pixarbio Corp









Robert S. Langer




 Acadia Healthcare Company Inc









William F. Grieco




 Air T, Inc.









Gary Sheldon Kohler




 GAMCO Global Gold Ntrl Rsrcs & Incm Trst









Vincent D. Enright




 Corbus Pharmaceuticals Holdings Inc









Sean F. Moran




 Gabelli Utility Trust









Vincent D. Enright




 Fluoropharma Medical Inc









Walter W. Witoshkin




 Gabelli Healthcare & WellnessRx Trust









Vincent D. Enright




 Puretech Health PLC









Robert S. Langer




Gecko Biomedical SAS
                                            








Robert S. Langer





Arcadia Strategies LLC
                                            








William F. Grieco





Micell Technologies, Inc.
                                            








Robert S. Langer





Blue Clay Capital Management LLC
                                            








Gary Sheldon Kohler





Arsenal Medical, Inc.
                                            








Robert S. Langer





FluoroPharma, Inc.
                                            








Walter W. Witoshkin





Gabelli Global Utility & Income Trust
                                            








Vincent D. Enright





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Lloyd Blankfein
Michael Bloomberg
Yannick Bollor�
Warren Buffett
Antony Burgmans
Jean-paul Clozel
Gary Cohn
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
Michel Landel
Daniel Loeb
Maurice L�vy
Jack Ma
Marissa Mayer
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
Xavier Niel
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Urs Rohner
Wilbur Ross
Charles Schwab
Igor Sechin
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :B�rse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright � 2017 Surperformance. All rights reserved.  












 














Slave







ALAN WAYNE  SCHOENBART - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











ALAN WAYNE  SCHOENBART
Check out list of companies and businesses related to ALAN WAYNE  SCHOENBART. Find out ALAN WAYNE  SCHOENBART address and contact details. View other people related to ALAN WAYNE  SCHOENBART - coworkers, colleagues, companions, etc.
Address:   

C/O ORTEC INTERNATIONAL, INC. 3960 BROADWAY NEW YORK 10032 NY




Companies related to ALAN WAYNE  SCHOENBART
CIKCompany NamePositionCompany Address0000889992Forticell BioScience, Inc.Chief Financial Officer 3960 BROADWAY,  NEW YORK 100320001031927Echo Therapeutics, Inc.CEO, CFO AND SECRETARY 99 WOOD AVENUE SOUTH SUITE 302 ISELIN 08830




ALAN WAYNE  SCHOENBART on the Web
Persons related to ALAN WAYNE  SCHOENBART - Forticell BioScience, Inc.NamePositionCityMark  BagnallDirector NEW YORKGREG  BROWNNEW YORKMARK  EISENBERGDirector DOVER HEIGHTS, AUSTRALIASHEPARD M  GOLDBERGDirector HEWLETTRaphael  HofsteinDirector NEW YORKGottlieb  JacobNEW YORKJG ASSET, LLCNEW YORKSTEVEN  KATZChairman NEW YORKJohn R  LeoneDirector ST. DAVIDSSTEVEN  LILIENDirector ARDSLEYRON  LIPSTEINCEO NEW YORKCOSTA  PAPSTEPHANOUChief Executive Officer NEW YORKALLEN I  SCHIFFDirector NEW YORKALAN WAYNE  SCHOENBARTChief Financial Officer NEW YORKSDS CAPITAL GROUP SPC LTD10% Owner GRAND CAYMANSDS MERCHANT FUND LPOLD GREENWICHVisium Asset Management, LPNEW YORKAndreas  VoglerNEW YORKAndreas  VoglerDirector NEW YORKPersons related to ALAN WAYNE  SCHOENBART - Echo Therapeutics, Inc.NamePositionCitySchoenbart  AlanIselinJOSEPH  AMARALJOSEPH  AMARALDirector FRANKLINCharles Thomas  Bernhardt IIIPHILADELPHIAKIMBERLY A  BURKEGENERAL COUNSEL PHILADELPHIAAllen Easley  CatoDURHAMHOLDING CO  CATODURHAMSchnittker  ChristopherPhiladelphiaTHOMAS W  DAVISONPresident and CEO FRANKLINTHOMAS W  DAVISONActing President and CEO FRANKLINRobert F  DomanEXEC. CHAIRMAN AND INTERIM CEO PHILADELPHIAElazer R  Edelman BROOKLINEEdelman  ElazerIselinVINCENT D  ENRIGHTRYEVINCENT D  ENRIGHTDirector FRANKLINVINCENT D  ENRIGHT FRANKLINVINCENT D  ENRIGHT PHILADELPHIAESSEX WOODLANDS HEALTH VENTURES FUND IV L P10% Owner THE WOODLANDSMICHAEL M  GOLDBERG SAN DIEGOMICHAEL M  GOLDBERG PHILADELPHIASHEPARD M  GOLDBERG TARRYTOWNSHEPARD M  GOLDBERG PHILADELPHIAWILLIAM  GRIECO PHILADELPHIAWILLIAM  GRIECO FRANKLINMITCHELL  HARRYFRANKLINScott Wayne  HollanderPRESIDENT AND CEO PHILADELPHIASMITH  JAMESFRANKLINSmith  JamesPhiladelphiaBURKE  KIMBERLYDURHAMBurke  KimberlyPhiladelphiaGARY S  KOHLERGARY S  KOHLERDirector MINNEAPOLISGARY S  KOHLERDirector FRANKLINURI  LANDESMANNEW YORKURI  LANDESMANNEW YORKURI  LANDESMANLONG ISLAND CITYROBERT  LANGERROBERT  LANGERDirector FRANKLINROBERT  LANGERDirector NEWTONBarry  MarstonVP of Sales & Marketing FRANKLINJAMES R  MCNABJAMES R  MCNABDirector CAMBRIDGEJAMES R  MCNABDirector FRANKLINGoldberg  MichaelIselinHarry  MitchellInterim CEO and CFO FRANKLINHarry  MitchellCFO AND COO FRANKLINHarry  MitchellChief Operating Officer/ CFO FRANKLINPATRICK T  MOONEYChief Executive Officer FRANKLINPATRICK T  MOONEYChief Executive Officer FRANKLINPATRICK T  MOONEYCEO AND PRESIDENT FRANKLINPATRICK T  MOONEYCEO AND PRESIDENT PHILADELPHIASEAN  MORANChief Financial Officer FRANKLINSEAN  MORANChief Financial Officer FRANKLINMark  NordlichtNEW ROCHELLEMark  Nordlicht10% Owner NEW YORKMark  Nordlicht10% Owner NEW YORKMOONEY  PATRICKHADDONFIELDPlatinum Liquid Opportunity Management (NY) LLCNEW YORKPlatinum Long Term Growth VII, LLCNEW YORKPlatinum Long Term Growth VII, LLCNEW YORKPlatinum Management (NY) LLCNEW YORKPlatinum Management (NY) LLCNEW YORKPlatinum-Montaur Life Sciences, LLCNEW YORKPlatinum-Montaur Life Sciences, LLCNEW YORKPlatinum Partners Liquid Opportunity Master Fund L.P.NEW YORKPlatinum Partners Liquid Opportunity Master Fund L.P.NEW YORKPlatinum Partners Value Arbitrage Fund, LPNEW YORKPlatinum Partners Value Arbitrage Fund, LPGEORGETOWN, GRAND CAYMANPlatinum Partners Value Arbitrage Fund, LPNEW YORKGERARD E  PUORRODirector FRANKLINDoman  RobertPhiladelphiaLANGER  ROBERTCAMBRIDGECHRISTOPHER P.  SCHNITTKERCFO PHILADELPHIAALAN WAYNE  SCHOENBARTCEO, CFO AND SECRETARY NEW YORKALAN WAYNE  SCHOENBARTPHILADELPHIAHollander  ScottIselinSINGH  SHAWNSAN CARLOSGoldberg  ShepardIselinShawn  SinghPresident (Interim) FRANKLINShawn  SinghPresident (interim) FRANKLINJAMES FRANCIS  SMITHFRANKLINJAMES FRANCIS  SMITH PHILADELPHIABRIAN F  SULLIVANMINNEAPOLISBRIAN F  SULLIVANDirector FRANKLINMARTIN P  SUTTERMARTIN P  SUTTERDirector THE WOODLANDSW LEIGH MD PHD  THOMPSONENRIGHT  VINCENTFRANKLINEnright  VincentPhiladelphiaWITOSHKIN  WALTERDOYLESTOWNWITOSHKIN  WALTERFRANKLINMICHAEL  WIGLEYDirector MICHAEL  WIGLEYDirector FRANKLINMICHAEL  WIGLEYDirector FRANKLINGRIECO  WILLIAMFRANKLINGrieco  WilliamPhiladelphiaWalter W  WitoshkinAMBLEWalter W  WitoshkinDirector FRANKLINWalter W  WitoshkinDirector FRANKLIN
Potentially same personNameCityCountryWayne  AlanFlowery BranchGA












 






        13D Filing: Alan Wayne Schoenbart and Echo Therapeutics Inc. (NASDAQ:ECTE) - Insider Monkey                                     
        Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.    
   Hedge Funds  13D Filing: Alan Wayne Schoenbart and Echo Therapeutics Inc. (NASDAQ:ECTE)    Published on April 8, 2017 at 10:46 pm by  
                                Insider Monkey Staff
                                  in Hedge Funds         Page 1 of 4Next &gt&gt          You can access the original SEC filing by clicking here. Ownership Summary Table   Name   Sole Voting Power   Shared Voting Power   Sole Dispositive Power   Shared Dispositive Power   Aggregate Amount Owned Power   Percent of Class    Alan W. Schoenbart   774,500   0   774,500   0   774,500   5.6%   Page 1 of 4 – SEC Filing           
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549   
SCHEDULE 13D 
(Rule 13d – 102)   
INFORMATION TO BE INCLUDED IN STATEMENTS FILED 
PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED
PURSUANT 
TO RULE 13d-2(a)     ECHO
THERAPEUTICS, INC. 
(Name of Issuer)   Common
Stock, par value $.01 per share 
(Title of Class of Securities)   27876L107 
(CUSIP Number)   Kevin
W. Waite, Esq. Moomjian,
Waite, Wactlar & Coleman, LLP 100
Jericho Quadrangle, Suite 208 Jericho,
New York 11753 (516)
937-5900 
(Name, Address and Telephone Number of Person Authorized
to 
Receive Notices and Communications)   March
21, 2017 
(Date of Event which Requires Filing of this
Statement)   If the
filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of Rule 13d-1(e), 13d-1(f), or
13d-1(g), check the following box [ ].   NOTE:
Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be
sent.   *The
remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing
information which would alter disclosure provided in a prior cover
page.   The
information required on the remainder of this cover page shall not
be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that Section of the Act but
shall be subject to all other provisions of the Act (however, see
the Notes).             Follow Echo Therapeutics Inc. (NASDAQ:ECTE)Follow Echo Therapeutics Inc. (NASDAQ:ECTE)       Trade (NASDAQ:ECTE) Now!        Page 1 of 4Next &gt&gt       Related Insider Monkey Articles13D Filing: Hudson Executive Capital and Cabot Microelectronics Corp (NASDAQ...13D Filing: Mill Road Capital Ii, L.p. and Ecology & Environment Inc (...13D Filing: Granite Falls Energy, Llc and Heron Lake Bioenergy Llc13D Filing: Maxlinear Inc and Exar Corp (NYSE:EXAR)13D Filing: Growth Equity Opportunities Iv, Llc and Aveo Pharmaceuticals Inc...13D Filing:  Junwei Zheng and Kiwa Bio-Tech Products Group Corp Echo Therapeutics Inc. (NASDAQ:ECTE) NASDAQ:ECTE Schoenbart Alan Wayne SEC 13D Filing                Insider Monkey Small Cap Strategy      Download a free copy of our newsletter and see the details inside!     Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds      Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000           About Us Contact Us Terms Of Use Privacy Policy       Next Post

   Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.            




Echo Therapeutics Inc (ECTE.PK)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Echo Therapeutics Inc (ECTE.PK)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareAdvanced Medical Equipment & Technology












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				ECTE.PK on OTC Markets Group


				0.05USD
21 Jul 2017





				    Change	(% chg)


		    
						    $0.00


					            (+0.00%)
					        






Prev Close

$0.05


Open

$0.05




Day's High

$0.05


Day's Low

$0.05




Volume

2,839


Avg. Vol

26,587




52-wk High

$1.25


52-wk Low

$0.04











					Summary





Name
Age
Since
Current Position




							Alan Schoenbart

58
2017

                                Chief Executive Officer, Chief Financial Officer, Secretary, Director




							Christine Olimpio




                                Director, Investor Relations & Corporate Communications



» Insider Trading





					Biographies





Name
Description




							Alan Schoenbart


					
							Mr. Alan W. Schoenbart, CPA, Chief Executive Officer, Chief Financial Officer, Secretary, Director of Echo Therapeutics, Inc. Mr. Schoenbart was named our Chief Financial Officer on December 29, 2014. Prior to joining Echo, Mr. Schoenbart served as Chief Financial Officer of Hudson News Distributors, LLC from June 2010 to December 2014. From March 2004 to June 2010, Mr. Schoenbart served as the CFO for Forticell Bioscience, Inc., a publicly-traded medical device company with an FDA approved product attempting to develop a cryopreserved product. Mr. Schoenbart has also held prior CFO positions at Vizacom Inc. and Windswept Environmental Group, Inc. Prior to that, he was an audit manager at KPMG LLP in Short Hills, New Jersey. Mr. Schoenbart received his B.S. degree in Accounting from Fairleigh Dickinson University and is a certified public accountant licensed in the States of New York and New Jersey.




							Christine Olimpio














					Basic Compensation





Name
Fiscal Year Total




							Alan Schoenbart

260,000




							Christine Olimpio

--



As Of 
30 Dec 2015





					Options Compensation





Name
Options
Value




							Alan Schoenbart

0
0




							Christine Olimpio

0
0









					Insider Trading












Name
Shares Traded
Price


Goldberg (Shepard M)
25,000
$0.00


Schoenbart (Alan Wayne)
100,000
$0.00


Goldberg (Michael M)
25,000
$0.00


Schoenbart (Alan Wayne)
28,000
$0.34


Schoenbart (Alan Wayne)
100,000
$0.00


Hollander (Scott Wayne)
150,000
$0.00




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareAdvanced Medical Equipment & Technology




















        13D Filing: Alan Wayne Schoenbart and Echo Therapeutics Inc. (NASDAQ:ECTE) - Insider Monkey                                      
        Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.    
   Hedge Funds  13D Filing: Alan Wayne Schoenbart and Echo Therapeutics Inc. (NASDAQ:ECTE)    Published on April 8, 2017 at 10:46 pm by  
                                Insider Monkey Staff
                                  in Hedge Funds         &lt&lt PreviousPage 3 of 4Next &gt&gtSee All          Page 3 of 4 – SEC Filing        
Item 1. Security and Issuer.   The
class of securities to which this statement relates is the common
stock, par value $0.01 per share (the “Common Stock”),
of Echo Therapeutics, Inc. (the “Company”). The
Company’s principal executive offices are located at 99 Wood
Avenue South., Suite 302, Iselin, NJ 08830.   
Item 2. Identity and Background.   (a)
This statement is being filed by Alan W. Schoenbart, the Chief
Executive Officer, Chief Financial Officer and director of the
Company.   (b) The
business address for Mr. Schoenbart is c/o Echo Therapeutics, Inc.,
99 Wood Avenue South., Suite 302, Iselin, NJ 08830.   (c) Mr.
Schoenbart is the Chief Executive Officer, Chief Financial Officer
and director of the Company. The address for the Company is set
forth above in Item 1.   (d) Mr.
Schoenbart has not, during the last five years, been convicted in a
criminal proceeding (excluding traffic violations or similar
misdemeanors).   (e) Mr.
Schoenbart has not, during the last five years, been a party to a
civil proceeding of a judicial or administrative body of competent
jurisdiction and was or is not as a result of such proceeding
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with
respect to such laws.   (f) Mr.
Schoenbart is a citizen of the United States.   
Item 3. Source and Amount of Funds or Other
Consideration.   The
response to Item 4 is incorporated herein by
reference.     Item
4.  Purpose
of Transaction     On
March 21, 2017, in connection with his appointment as Chief
Executive Officer, the Company granted to Mr. Schoenbart an option
(“Option”) to purchase 500,000 shares of Common Stock
pursuant to the Company’s 2008 Equity Incentive Plan. The
Option has a term of 10 years, an exercise price of $0.16 per
share, the closing price of the Common Stock on the date of grant,
and vested in full immediately on grant. Mr. Schoenbart was also
granted 100,000 restricted shares of Common Stock pursuant to the
Company’s 2008 Equity Incentive Plan, which shares vested in
full immediately on grant.   Except
as set forth herein, the Reporting Persons has no present plan or
proposal that would relate to or result in any of the matters set
forth in subparagraphs (a)-(j) of Item 4 of Schedule
13D.   
Item 5. Interest in Securities of the Issuer.   (a) The
aggregate number of shares of Common Stock beneficially owned by
the Reporting Person is 774,500, of which 600,000 shares are
underlying currently exercisable stock options. Such amount
represents beneficial ownership of 5.6% of the Common Stock of the
Company (based on 13,197,278 shares outstanding as of the date
hereof).   (b) The
number of shares of Common Stock as to which Mr. Schoenbart
has:   1. Sole
power to vote or to direct vote is 774,500. 2. Shared
power to vote or to direct vote is 0. 3. Sole
power to dispose or to direct the disposition is
774,500. 4. Shared
power to dispose or to direct the disposition is 0.   (c) On
March 21, 2017, in connection with his appointment as Chief
Executive Officer, the Company granted to Mr. Schoenbart the Option
to purchase 500,000 shares of Common Stock and 100,000 restricted
shares of Common Stock. Other than the forgoing, Mr. Schoenbart has
not effected any transactions with respect to any securities of the
Company during the past sixty days.   (d) Not
Applicable.   (e) Not
Applicable.   
Item 6. Contracts, Arrangements, Understandings or Relationships
with Respect to the 
Securities
of the Issuer   None.   
Item 7. Material to be Filed as Exhibits.   None.          Follow Echo Therapeutics Inc. (NASDAQ:ECTE)Follow Echo Therapeutics Inc. (NASDAQ:ECTE)       Trade (NASDAQ:ECTE) Now!        &lt&lt PreviousPage 3 of 4Next &gt&gtSee All       Related Insider Monkey Articles13D Filing: Hudson Executive Capital and Cabot Microelectronics Corp (NASDAQ...13D Filing: Mill Road Capital Ii, L.p. and Ecology & Environment Inc (...13D Filing: Granite Falls Energy, Llc and Heron Lake Bioenergy Llc13D Filing: Maxlinear Inc and Exar Corp (NYSE:EXAR)13D Filing: Growth Equity Opportunities Iv, Llc and Aveo Pharmaceuticals Inc...13D Filing:  Junwei Zheng and Kiwa Bio-Tech Products Group Corp Echo Therapeutics Inc. (NASDAQ:ECTE) NASDAQ:ECTE Schoenbart Alan Wayne SEC 13D Filing                Insider Monkey Small Cap Strategy      Download a free copy of our newsletter and see the details inside!     Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds      Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000           About Us Contact Us Terms Of Use Privacy Policy       Next Post

   Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.            



